SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:lup.lub.lu.se:41e2a13a-ee9a-4633-bac9-189ca386b82d"
 

Search: onr:"swepub:oai:lup.lub.lu.se:41e2a13a-ee9a-4633-bac9-189ca386b82d" > FKBPL: a marker of ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

FKBPL: a marker of good prognosis in breast cancer.

Nelson, Laura (author)
McKeen, Hayley D (author)
Marshall, Andrea (author)
show more...
Mulrane, Laoighse (author)
Starczynski, Jane (author)
Storr, Sarah J (author)
Lanigan, Fiona (author)
Byrne, Christopher (author)
Arthur, Ken (author)
Hegarty, Shauna (author)
Ali, Ahlam Abdunnabi (author)
Furlong, Fiona (author)
McCarthy, Helen O (author)
Ellis, Ian O (author)
Green, Andrew R (author)
Rakha, Emad (author)
Young, Leonie (author)
Kunkler, Ian (author)
Thomas, Jeremy (author)
Jack, Wilma (author)
Cameron, David (author)
Jirström, Karin (author)
Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine
Yakkundi, Anita (author)
McClements, Lana (author)
Martin, Stewart G (author)
Gallagher, William M (author)
Dunn, Janet (author)
Bartlett, John (author)
O'Connor, Darran (author)
Robson, Tracy (author)
show less...
 (creator_code:org_t)
2015-04-03
2015
English.
In: Oncotarget. - : Impact Journals, LLC. - 1949-2553. ; 6:14, s. 12209-12223
Related links:
https://portal.resea... (primary) (free)
show more...
http://www.ncbi.nlm.... (free)
http://dx.doi.org/10... (free)
http://www.oncotarge...
https://lup.lub.lu.s...
https://doi.org/10.1...
show less...
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • FK506-binding protein-like (FKBPL) has established roles as an anti-tumor protein, with a therapeutic peptide based on this protein, ALM201, shortly entering phase I/II clinical trials. Here, we evaluated FKBPL's prognostic ability in primary breast cancer tissue, represented on tissue microarrays (TMA) from 3277 women recruited into five independent retrospective studies, using immunohistochemistry (IHC). In a meta-analysis, FKBPL levels were a significant predictor of BCSS; low FKBPL levels indicated poorer breast cancer specific survival (BCSS) (hazard ratio (HR) = 1.30, 95% confidence interval (CI) 1.14-1.49, p < 0.001). The prognostic impact of FKBPL remained significant after adjusting for other known prognostic factors (HR = 1.25, 95% CI 1.07-1.45, p = 0.004). For the sub-groups of 2365 estrogen receptor (ER) positive patients and 1649 tamoxifen treated patients, FKBPL was significantly associated with BCSS (HR = 1.34, 95% CI 1.13-1.58, p < 0.001, and HR = 1.25, 95% CI 1.04-1.49, p = 0.02, respectively). A univariate analysis revealed that FKBPL was also a significant predictor of relapse free interval (RFI) within the ER positive patient group, but it was only borderline significant within the smaller tamoxifen treated patient group (HR = 1.32 95% CI 1.05-1.65, p = 0.02 and HR = 1.23 95% CI 0.99-1.54, p = 0.06, respectively). The data suggests a role for FKBPL as a prognostic factor for BCSS, with the potential to be routinely evaluated within the clinic.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

  • Oncotarget (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view